Sionna Therapeutics, Inc.
SION
$37.17
-$0.15-0.40%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.44M | -20.28M | -18.07M | -16.48M | -15.85M |
| Total Depreciation and Amortization | 152.00K | 189.00K | 147.00K | 159.00K | 167.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.96M | 2.96M | 2.16M | 1.89M | 764.00K |
| Change in Net Operating Assets | -302.00K | 1.90M | -2.40M | -1.85M | 3.14M |
| Cash from Operations | -16.63M | -15.23M | -18.15M | -16.29M | -11.78M |
| Capital Expenditure | -204.00K | -87.00K | 0.00 | -86.00K | -27.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 22.79M | 23.19M | -23.25M | -141.11M | 15.26M |
| Cash from Investing | 22.59M | 23.10M | -23.25M | -141.19M | 15.23M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.66M | 1.97M | -- | 202.39M | 25.00K |
| Repurchase of Common Stock | -- | -- | -312.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -1.43M |
| Cash from Financing | 1.66M | 1.97M | -312.00K | 202.39M | -1.41M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.62M | 9.85M | -41.71M | 44.91M | 2.04M |